Brief: Beyond Air Announces Positive Preclinical Data On Role Of Nitric Oxide In Autism Spectrum Disorder
07/08/2023 21:09
Aug 7 (Reuters) - Beyond Air Inc XAIR.O :
* BEYOND AIR® ANNOUNCES POSITIVE PRECLINICAL DATA ON ROLE OF
NITRIC OXIDE IN AUTISM SPECTRUM DISORDER (ASD)
Source text for Eikon: ID:nGNX4pcwxl
Further company coverage: XAIR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Beyond Air
See all newsBrief: Beyond Air Enters Definitive Agreement To Sell Its NeuroNOS Stake To UNIVO Pharmaceutical Industries In Exchange For Equity And Milestone Payments
Beyond Air Inc reports results for the quarter ended June 30 - Earnings Summary
Beyond Air Q1 net loss slightly widens, reaffirms 2026 outlook
Beyond Air Inc expected to post a loss of $10.80 a share - Earnings Preview
NASDAQ RESUMED AT 04:00 AM